Acetylcholine Release Inhibitor [EPC]

Acetylcholine Release Inhibitor [EPC] was reported 99109 times

These side effects are most commonly reported by patients taking drugs of the Acetylcholine Release Inhibitor [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 33273
1 OFF LABEL USE 18529
2 HEADACHE 6069
3 THERAPEUTIC RESPONSE DECREASED 5306
4 PRODUCT PREPARATION ERROR 4403
5 INJECTION SITE PAIN 4288
6 EYELID PTOSIS 3819
7 MIGRAINE 3565
8 NAUSEA 3411
9 PAIN 3204
10 DIZZINESS 3054
11 FATIGUE 3049
12 MUSCULAR WEAKNESS 2925
13 MULTIPLE USE OF SINGLE-USE PRODUCT 2869
14 DYSPNOEA 2536
15 DYSPHAGIA 2409
16 ASTHENIA 2401
17 HYPOAESTHESIA 2236
18 PRODUCT USE IN UNAPPROVED INDICATION 2047
19 DEATH 1996
20 RASH 1987
21 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1920
22 NECK PAIN 1890
23 PARAESTHESIA 1879
24 VISION BLURRED 1851
25 VOMITING 1781
26 THERAPEUTIC PRODUCT EFFECT DECREASED 1730
27 MALAISE 1657
28 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1642
29 HYPERSENSITIVITY 1641
30 SWELLING FACE 1619
31 INJECTION SITE SWELLING 1592
32 MUSCLE SPASMS 1563
33 URTICARIA 1559
34 SWELLING 1533
35 DRUG INTOLERANCE 1501
36 DIARRHOEA 1486
37 THERAPEUTIC RESPONSE SHORTENED 1466
38 ARTHRALGIA 1460
39 CONDITION AGGRAVATED 1434
40 ANXIETY 1414
41 DEPRESSION 1407
42 DRY MOUTH 1364
43 PRODUCT QUALITY ISSUE 1318
44 PRODUCT STORAGE ERROR 1311
45 ALOPECIA 1290
46 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1255
47 HYPERTENSION 1254
48 INSOMNIA 1251
49 FALL 1211
50 MATERNAL EXPOSURE DURING PREGNANCY 1202
51 INFLUENZA LIKE ILLNESS 1200
52 ABDOMINAL PAIN UPPER 1191
53 PRURITUS 1180
54 PRODUCT PREPARATION ISSUE 1145
55 PNEUMONIA 1143
56 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1138
57 CONFUSIONAL STATE 1135
58 MEMORY IMPAIRMENT 1129
59 GASTROOESOPHAGEAL REFLUX DISEASE 1126
60 MUSCULOSKELETAL STIFFNESS 1126
61 PAIN IN EXTREMITY 1099
62 BLEPHAROSPASM 1052
63 DRUG HYPERSENSITIVITY 1050
64 EPILEPSY 1042
65 FEELING ABNORMAL 1035
66 FACIAL PARESIS 1032
67 OVERDOSE 1027
68 PYREXIA 1010
69 ABDOMINAL DISCOMFORT 998
70 INTENTIONAL PRODUCT USE ISSUE 995
71 NASOPHARYNGITIS 987
72 WEIGHT INCREASED 962
73 INJECTION SITE ERYTHEMA 957
74 GENERAL PHYSICAL HEALTH DETERIORATION 931
75 RHEUMATOID ARTHRITIS 924
76 INFLAMMATION 921
77 SYSTEMIC LUPUS ERYTHEMATOSUS 919
78 ERYTHEMA 904
79 PERIPHERAL SWELLING 904
80 HYPERHIDROSIS 900
81 WEIGHT DECREASED 900
82 PSORIATIC ARTHROPATHY 898
83 ARTHROPATHY 891
84 DYSPHONIA 882
85 INFUSION RELATED REACTION 880
86 BLISTER 869
87 PRODUCT USE ISSUE 867
88 EYE SWELLING 851
89 TYPE 2 DIABETES MELLITUS 845
90 CONTUSION 840
91 PEMPHIGUS 837
92 FIBROMYALGIA 829
93 PERICARDITIS 827
94 BURSITIS 826
95 MUSCULOSKELETAL PAIN 826
96 SYNOVITIS 822
97 MOBILITY DECREASED 818
98 GLOSSODYNIA 815
99 TASTE DISORDER 812
100 BREAST CANCER STAGE III 802
101 FOLLICULITIS 801
102 JOINT SWELLING 800
103 GAIT DISTURBANCE 799
104 C-REACTIVE PROTEIN INCREASED 795
105 DUODENAL ULCER PERFORATION 793
106 HAND DEFORMITY 778
107 BLOOD CHOLESTEROL INCREASED 775
108 WOUND 774
109 STOMATITIS 773
110 VISUAL IMPAIRMENT 773
111 WHEEZING 772
112 DIPLOPIA 768
113 HELICOBACTER INFECTION 765
114 DYSPEPSIA 752
115 HEPATIC ENZYME INCREASED 752
116 GAIT INABILITY 751
117 FACET JOINT SYNDROME 746
118 INJECTION SITE REACTION 738
119 OSTEOARTHRITIS 737
120 TREATMENT FAILURE 737
121 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 719
122 CONTRAINDICATED PRODUCT ADMINISTERED 718
123 WOUND INFECTION 718
124 IRRITABLE BOWEL SYNDROME 711
125 SLEEP DISORDER 711
126 BOTULISM 710
127 BURNING SENSATION 701
128 LOWER RESPIRATORY TRACT INFECTION 700
129 TREMOR 694
130 IMPAIRED HEALING 693
131 URINARY TRACT INFECTION 691
132 JOINT RANGE OF MOTION DECREASED 685
133 MUSCLE INJURY 680
134 DISCOMFORT 670
135 LIP DRY 665
136 LUNG DISORDER 665
137 DECREASED APPETITE 661
138 BACK PAIN 660
139 NIGHT SWEATS 654
140 HYPERCHOLESTEROLAEMIA 653
141 GASTROINTESTINAL DISORDER 641
142 NAIL DISORDER 640
143 PERIPHERAL VENOUS DISEASE 638
144 DRY EYE 634
145 LIVER INJURY 627
146 DRUG EFFECT LESS THAN EXPECTED 626
147 LIVE BIRTH 625
148 OBESITY 624
149 SPEECH DISORDER 621
150 BROW PTOSIS 614
151 EXPOSURE DURING PREGNANCY 614
152 CHEST PAIN 611
153 MYALGIA 607
154 BACK INJURY 596
155 COUGH 584
156 INJECTION SITE BRUISING 584
157 INJURY 575
158 ONYCHOMADESIS 563
159 PALPITATIONS 560
160 ABDOMINAL PAIN 556
161 CONSTIPATION 554
162 ABDOMINAL DISTENSION 553
163 ADVERSE DRUG REACTION 553
164 SEDATION 549
165 RHEUMATIC FEVER 548
166 INJECTION SITE MASS 547
167 NIGHTMARE 547
168 VERTIGO 532
169 SINUSITIS 527
170 NEPHROLITHIASIS 526
171 POOR QUALITY PRODUCT ADMINISTERED 523
172 SOMNOLENCE 519
173 INJECTION SITE RASH 515
174 GRIP STRENGTH DECREASED 505
175 ILL-DEFINED DISORDER 502
176 EYELID OEDEMA 501
177 EYE PAIN 500
178 ADVERSE EVENT 499
179 ASTHMA 498
180 FACIAL PARALYSIS 492
181 INCORRECT DOSE ADMINISTERED 487
182 LIVER FUNCTION TEST INCREASED 486
183 THERAPY NON-RESPONDER 480
184 DRUG-INDUCED LIVER INJURY 475
185 INJECTION SITE PRURITUS 474
186 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 473
187 SEIZURE 470
188 CEREBROVASCULAR ACCIDENT 468
189 COVID-19 443
190 HEAD DISCOMFORT 431
191 CHEST DISCOMFORT 427
192 COELIAC DISEASE 426
193 ONYCHOMYCOSIS 423
194 URINARY RETENTION 422
195 SWOLLEN TONGUE 418
196 LOSS OF CONSCIOUSNESS 412
197 MUSCLE TWITCHING 412
198 OROPHARYNGEAL PAIN 406
199 INTENTIONAL PRODUCT MISUSE 404
200 DYSARTHRIA 394
201 C-REACTIVE PROTEIN ABNORMAL 393
202 TINNITUS 393
203 UNDERDOSE 391
204 PRESCRIBED OVERDOSE 390
205 FACIAL PAIN 384
206 BALANCE DISORDER 381
207 PRODUCT DOSE OMISSION ISSUE 377
208 ADVERSE REACTION 375
209 HEPATITIS 372
210 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 371
211 SKIN WRINKLING 369
212 ANGIOEDEMA 361
213 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 361
214 INFECTION 359
215 FINGER DEFORMITY 355
216 BLOOD PRESSURE INCREASED 351
217 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 339
218 FACIAL ASYMMETRY 338
219 MUSCLE TIGHTNESS 336
220 CHILLS 334
221 HEART RATE INCREASED 332
222 LACRIMATION INCREASED 332
223 SKIN TIGHTNESS 330
224 ILLNESS 328
225 PRODUCT LABEL CONFUSION 328
226 FEELING HOT 325
227 HYPOTENSION 325
228 SURGERY 323
229 INFLUENZA 322
230 ACCIDENTAL EXPOSURE TO PRODUCT 319
231 AMNESIA 315
232 PANIC ATTACK 313
233 PHOTOPHOBIA 312
234 PERIORBITAL SWELLING 311
235 HOSPITALISATION 308
236 PREGNANCY 305
237 THROAT TIGHTNESS 298
238 EYE DISORDER 295
239 LIP SWELLING 294
240 FOETAL EXPOSURE DURING PREGNANCY 293
241 STRESS 290
242 INJECTION SITE HAEMORRHAGE 289
243 OCULAR HYPERAEMIA 288
244 FLUSHING 284
245 INJECTION SITE URTICARIA 283
246 UNEVALUABLE EVENT 282
247 DRUG EFFECT DECREASED 280
248 SYNCOPE 280
249 MUSCLE SPASTICITY 274
250 PARALYSIS 273
251 URINARY INCONTINENCE 266
252 EAR PAIN 262
253 EYE IRRITATION 262
254 SKIN DISORDER 258
255 CONGENITAL ANOMALY 252
256 ARTHRITIS 248
257 ROAD TRAFFIC ACCIDENT 245
258 INFUSION SITE REACTION 242
259 HYPOAESTHESIA ORAL 239
260 NEURALGIA 238
261 TACHYCARDIA 235
262 DISTURBANCE IN ATTENTION 232
263 SWELLING OF EYELID 232
264 DYSGEUSIA 231
265 OEDEMA 230
266 SKIN DISCOLOURATION 224
267 UPPER RESPIRATORY TRACT INFECTION 219
268 CHOKING 216
269 PAIN IN JAW 216
270 SUICIDAL IDEATION 216
271 RESPIRATORY DISORDER 212
272 PSORIASIS 211
273 DEHYDRATION 209
274 DYSKINESIA 209
275 AUTOIMMUNE DISORDER 208
276 OEDEMA PERIPHERAL 207
277 NEUROMUSCULAR TOXICITY 206
278 ANAPHYLACTIC REACTION 205
279 LETHARGY 200
280 BRONCHITIS 199
281 HERPES ZOSTER 198
282 MULTIPLE SCLEROSIS 197
283 MUSCLE ATROPHY 197
284 APHASIA 196
285 INJECTION SITE NODULE 195
286 MASS 195
287 EYE PRURITUS 192
288 LYMPHADENOPATHY 192
289 PRODUCT TEMPERATURE EXCURSION ISSUE 192
290 THERAPEUTIC RESPONSE UNEXPECTED 192
291 ASTHENOPIA 190
292 IMPAIRED WORK ABILITY 184
293 JOINT STIFFNESS 183
294 LOWER LIMB FRACTURE 183
295 DRUG INTERACTION 179
296 DRUG RESISTANCE 176
297 THROAT IRRITATION 173
298 TOXICITY TO VARIOUS AGENTS 171
299 LARYNGITIS 170
300 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 170
301 INJECTION SITE DISCOMFORT 168
302 RHINORRHOEA 168
303 ACNE 167
304 NERVE INJURY 165
305 RASH ERYTHEMATOUS 165
306 NO ADVERSE EVENT 164
307 PERIORBITAL OEDEMA 164
308 EXOSTOSIS 161
309 MULTIPLE SCLEROSIS RELAPSE 161
310 NASAL CONGESTION 160
311 SENSORY DISTURBANCE 158
312 MOVEMENT DISORDER 156
313 PATIENT DISSATISFACTION WITH TREATMENT 155
314 PNEUMONIA ASPIRATION 155
315 POOR QUALITY DRUG ADMINISTERED 155
316 NEUROPATHY PERIPHERAL 154
317 RED BLOOD CELL SEDIMENTATION RATE INCREASED 153
318 COGNITIVE DISORDER 151
319 MASTICATION DISORDER 151
320 OCULAR DISCOMFORT 150
321 PULMONARY FIBROSIS 150
322 NODULE 149
323 BRAIN FOG 148
324 CELLULITIS 148
325 DRY SKIN 148
326 MEDICATION ERROR 148
327 CYSTITIS 147
328 EAR DISCOMFORT 147
329 BLINDNESS 146
330 CARDIAC DISORDER 146
331 INCORRECT ROUTE OF DRUG ADMINISTRATION 146
332 RESPIRATORY FAILURE 146
333 TENSION HEADACHE 145
334 BREAST CANCER STAGE II 144
335 PRESCRIBED UNDERDOSE 144
336 OSTEOPOROSIS 143
337 TENDERNESS 143
338 DYSSTASIA 142
339 DYSURIA 141
340 SEPSIS 141
341 CROHN^S DISEASE 140
342 VISUAL ACUITY REDUCED 140
343 CHRONIC KIDNEY DISEASE 139
344 SWOLLEN JOINT COUNT INCREASED 139
345 PRESYNCOPE 137
346 DISLOCATION OF VERTEBRA 135
347 RASH PAPULAR 135
348 SCIATICA 135
349 DEPRESSED MOOD 134
350 NORMAL NEWBORN 134
351 HALLUCINATION 133
352 ENDOMETRIOSIS 132
353 PRODUCT DISTRIBUTION ISSUE 132
354 DELIRIUM 131
355 LIMB DISCOMFORT 131
356 BONE EROSION 130
357 RASH PRURITIC 130
358 RHEUMATOID FACTOR POSITIVE 130
359 DRUG EFFECT INCOMPLETE 129
360 EMOTIONAL DISTRESS 129
361 HOT FLUSH 126
362 DISORIENTATION 125
363 BLOOD PRESSURE DECREASED 123
364 ASPIRATION 122
365 EAR INFECTION 122
366 NERVOUSNESS 122
367 VIRAL INFECTION 122
368 HAEMORRHAGE 121
369 MYOCARDIAL INFARCTION 121
370 INJECTION SITE PAPULE 120
371 NEOPLASM MALIGNANT 120
372 SKIN EXFOLIATION 119
373 DEVICE DIFFICULT TO USE 118
374 DISABILITY 118
375 INJECTION SITE OEDEMA 118
376 IRRITABILITY 118
377 VIITH NERVE PARALYSIS 118
378 ABORTION SPONTANEOUS 117
379 PALLOR 117
380 FACE OEDEMA 116
381 NERVOUS SYSTEM DISORDER 116
382 DYSTONIA 115
383 LIVER DISORDER 115
384 OVERLAP SYNDROME 115
385 HYPOTONIA 114
386 THERAPY CESSATION 114
387 DEEP VEIN THROMBOSIS POSTOPERATIVE 113
388 INJECTION SITE HAEMATOMA 113
389 MUSCULOSKELETAL DISCOMFORT 113
390 EYE DISCHARGE 112
391 FEEDING DISORDER 112
392 HEPATIC CIRRHOSIS 112
393 SKIN BURNING SENSATION 112
394 OXYGEN SATURATION DECREASED 111
395 CONCUSSION 110
396 HEAD INJURY 110
397 INJECTION SITE INFLAMMATION 110
398 POOR QUALITY SLEEP 110
399 ANAEMIA 109
400 MUSCULOSKELETAL DISORDER 109
401 POLLAKIURIA 109
402 INCORRECT PRODUCT ADMINISTRATION DURATION 108
403 PARAESTHESIA ORAL 108
404 DROOLING 107
405 X-RAY ABNORMAL 107
406 BREAST CANCER 106
407 CRYING 106
408 EYELID DISORDER 106
409 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 105
410 APHONIA 105
411 IMPAIRED DRIVING ABILITY 105
412 MENTAL DISORDER 105
413 INJECTION SITE DISCOLOURATION 104
414 MUSCLE DISORDER 103
415 PRODUCT DOSE OMISSION 102
416 SINUS DISORDER 102
417 TORTICOLLIS 102
418 CATARACT 101
419 CONVULSION 101
420 LUPUS VULGARIS 101
421 WHITE BLOOD CELL COUNT DECREASED 101
422 JOINT DISLOCATION 100
423 PULMONARY EMBOLISM 100
424 THERAPY INTERRUPTED 100
425 WHITE BLOOD CELL COUNT INCREASED 100
426 ATRIAL FIBRILLATION 98
427 DRUG DOSE OMISSION BY DEVICE 98
428 BONE PAIN 97
429 DRUG ADMINISTERED AT INAPPROPRIATE SITE 97
430 FREQUENT BOWEL MOVEMENTS 97
431 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 97
432 HYPOACUSIS 96
433 INCORRECT PRODUCT STORAGE 96
434 LUPUS-LIKE SYNDROME 96
435 PRODUCT ADMINISTRATION ERROR 96
436 EYE MOVEMENT DISORDER 95
437 LAGOPHTHALMOS 95
438 SCAR 95
439 ULCER HAEMORRHAGE 95
440 PRODUCT DISPENSING ERROR 94
441 EXPIRED PRODUCT ADMINISTERED 93
442 FACIAL DISCOMFORT 93
443 DEPRESSED LEVEL OF CONSCIOUSNESS 92
444 BODY TEMPERATURE INCREASED 91
445 PHARYNGEAL OEDEMA 91
446 PRODUCTIVE COUGH 90
447 TRISMUS 90
448 VITREOUS FLOATERS 90
449 DRUG SPECIFIC ANTIBODY 89
450 FACIAL SPASM 89
451 INJECTION SITE WARMTH 89
452 MADAROSIS 88
453 TRANSIENT ISCHAEMIC ATTACK 87
454 DEVICE ISSUE 86
455 HEMIPARESIS 86
456 DRUG TOLERANCE 85
457 POST PROCEDURAL COMPLICATION 85
458 RECTAL HAEMORRHAGE 85
459 RESPIRATORY TRACT INFECTION 85
460 MENTAL IMPAIRMENT 84
461 MYDRIASIS 84
462 THROMBOSIS 84
463 INJECTION SITE INDURATION 83
464 MYASTHENIA GRAVIS 83
465 PHOTOSENSITIVITY REACTION 83
466 SENSATION OF FOREIGN BODY 83
467 DEAFNESS 82
468 IMPAIRED GASTRIC EMPTYING 82
469 POSTURE ABNORMAL 82
470 RASH GENERALISED 82
471 TOOTHACHE 82
472 DRUG DOSE OMISSION 81
473 INJECTION SITE HYPOAESTHESIA 81
474 LIP DISORDER 81
475 PANCREATITIS 81
476 SNEEZING 81
477 AGITATION 80
478 FEAR 80
479 FLUID RETENTION 80
480 KNEE ARTHROPLASTY 80
481 MIDDLE INSOMNIA 80
482 PRODUCT COMPLAINT 80
483 SLEEP APNOEA SYNDROME 80
484 SPINAL OPERATION 80
485 FEELING COLD 79
486 PAIN OF SKIN 79
487 STRABISMUS 79
488 ACTIVITIES OF DAILY LIVING IMPAIRED 78
489 EATING DISORDER 78
490 EYE CONTUSION 78
491 RIB FRACTURE 78
492 EXTRAPYRAMIDAL DISORDER 77
493 HEART RATE DECREASED 77
494 INJECTION SITE PARAESTHESIA 77
495 ABNORMAL SENSATION IN EYE 76
496 BRAIN INJURY 76
497 EYELID SENSORY DISORDER 76
498 HEPATIC ENZYME 75
499 INJECTION SITE HYPERSENSITIVITY 75
500 INTERVERTEBRAL DISC PROTRUSION 75
501 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 75
502 PRODUCT PHYSICAL ISSUE 75
503 MICTURITION URGENCY 74
504 PARADOXICAL DRUG REACTION 74
505 AGEUSIA 73
506 BELL^S PALSY 73
507 BLADDER DISORDER 73
508 PRURITUS GENERALISED 73
509 RASH MACULAR 73
510 ARRHYTHMIA 71
511 BEDRIDDEN 71
512 ECZEMA 71
513 GENERAL PHYSICAL CONDITION ABNORMAL 71
514 HYPOCHOLESTEROLAEMIA 70
515 HYPOTHYROIDISM 70
516 COLITIS ULCERATIVE 69
517 HYPOKINESIA 69
518 INCONTINENCE 69
519 INJECTION SITE IRRITATION 69
520 VISUAL FIELD DEFECT 69
521 WALKING AID USER 69
522 BLOOD GLUCOSE INCREASED 68
523 HEART RATE IRREGULAR 68
524 HYPERACUSIS 68
525 MEPHISTO SIGN 68
526 ANGINA PECTORIS 67
527 ERYTHEMA OF EYELID 67
528 CARDIAC ARREST 66
529 CHOKING SENSATION 66
530 EYE INFECTION 66
531 SINUS CONGESTION 66
532 SUSPECTED COUNTERFEIT PRODUCT 66
533 COLD SWEAT 65
534 DIABETES MELLITUS 65
535 EPISTAXIS 65
536 HIP ARTHROPLASTY 65
537 PRODUCT PACKAGING ISSUE 65
538 RETINITIS 65
539 SALIVARY HYPERSECRETION 65
540 SKIN IRRITATION 65
541 SUSPECTED PRODUCT QUALITY ISSUE 65
542 THERAPY PARTIAL RESPONDER 65
543 BRADYCARDIA 64
544 INSURANCE ISSUE 64
545 PARANASAL SINUS DISCOMFORT 64
546 RESPIRATORY DISTRESS 64
547 SKIN MASS 64
548 TRIGEMINAL NEURALGIA 64
549 ANURIA 63
550 IMPAIRED QUALITY OF LIFE 63
551 MUSCLE CONTRACTIONS INVOLUNTARY 63
552 OPHTHALMOPLEGIA 63
553 ABASIA 62
554 BACK DISORDER 62
555 FACIAL PALSY 62
556 LIMB INJURY 62
557 LOCAL SWELLING 62
558 PANIC REACTION 62
559 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 62
560 DEFORMITY 61
561 EMOTIONAL DISORDER 61
562 HAEMATOMA 61
563 INJECTION SITE INDENTATION 61
564 ORAL DISCOMFORT 61
565 C-REACTIVE PROTEIN 60
566 DEEP VEIN THROMBOSIS 60
567 DRUG SPECIFIC ANTIBODY PRESENT 60
568 FOOT DEFORMITY 60
569 HAEMOGLOBIN DECREASED 60
570 HYPERAESTHESIA 60
571 HYPOPHAGIA 60
572 MYOSITIS 60
573 NEOVASCULARISATION 60
574 ANAPHYLACTIC SHOCK 59
575 INJECTION SITE VESICLES 59
576 KIDNEY INFECTION 59
577 SKIN INDENTATION 59
578 SKIN LESION 59
579 DRY THROAT 58
580 FUNGAL INFECTION 58
581 LABORATORY TEST ABNORMAL 58
582 PHARYNGEAL SWELLING 58
583 POST-TRAUMATIC NECK SYNDROME 58
584 THINKING ABNORMAL 58
585 CONJUNCTIVITIS 57
586 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 57
587 HYPERSOMNIA 57
588 IMMUNODEFICIENCY 57
589 MATERNAL EXPOSURE TIMING UNSPECIFIED 57
590 OROPHARYNGEAL DISCOMFORT 57
591 PRODUCT CONTAINER ISSUE 57
592 RESTLESS LEGS SYNDROME 57
593 SEASONAL ALLERGY 57
594 APPLICATION SITE PAIN 56
595 HAEMATURIA 56
596 OTITIS MEDIA 56
597 PARKINSON^S DISEASE 56
598 PROCEDURAL PAIN 56
599 STAPHYLOCOCCAL INFECTION 56
600 THIRST 56
601 OCCUPATIONAL EXPOSURE TO PRODUCT 55
602 THERAPEUTIC RESPONSE DELAYED 55
603 BLINDNESS UNILATERAL 54
604 BLOOD POTASSIUM DECREASED 54
605 DERMATITIS 54
606 DERMATITIS CONTACT 54
607 DEVICE MALFUNCTION 54
608 DYSPNOEA EXERTIONAL 54
609 INCORRECT PRODUCT FORMULATION ADMINISTERED 54
610 MOTOR DYSFUNCTION 54
611 MUSCLE RIGIDITY 54
612 MUSCLE STRAIN 54
613 SEROTONIN SYNDROME 54
614 THERAPEUTIC PRODUCT EFFECT VARIABLE 54
615 ANOSMIA 53
616 CEREBRAL HAEMORRHAGE 53
617 MOOD ALTERED 53
618 ORAL PAIN 53
619 PORPHYRIA ACUTE 53
620 THERAPEUTIC PRODUCT EFFECT DELAYED 53
621 MONOPLEGIA 52
622 PRE-EXISTING CONDITION IMPROVED 52
623 RASH VESICULAR 52
624 SPINAL PAIN 52
625 TREATMENT NONCOMPLIANCE 52
626 BLINDNESS TRANSIENT 51
627 CYST 51
628 ELECTRIC SHOCK SENSATION 51
629 GUILLAIN-BARRE SYNDROME 51
630 HIP FRACTURE 51
631 HYPOAESTHESIA FACIAL 51
632 INTESTINAL OBSTRUCTION 51
633 ORAL HERPES 51
634 PHOTOPSIA 51
635 COMA 50
636 FOREIGN BODY SENSATION IN EYES 50
637 JAW DISORDER 50
638 PERIPHERAL COLDNESS 50
639 PRODUCT ADMINISTRATION INTERRUPTED 50
640 PRODUCT PACKAGING QUANTITY ISSUE 50
641 RENAL FAILURE 50
642 RESPIRATORY ARREST 50
643 ACUTE KIDNEY INJURY 49
644 GASTROENTERITIS VIRAL 49
645 HYPOKALAEMIA 49
646 PAPULE 49
647 PRODUCT SUPPLY ISSUE 49
648 RETCHING 49
649 SKIN HYPERPIGMENTATION 49
650 DIVERTICULITIS 48
651 GASTRIC DISORDER 48
652 HYPERTONIC BLADDER 48
653 MIGRAINE WITH AURA 48
654 SENSORY LOSS 48
655 SEPTIC SHOCK 48
656 TOOTH DISORDER 48
657 WITHDRAWAL SYNDROME 48
658 CHOLELITHIASIS 47
659 INJECTION SITE INFECTION 47
660 MASTOIDITIS 47
661 PAROSMIA 47
662 REDUCED FACIAL EXPRESSION 47
663 RENAL DISORDER 47
664 SECRETION DISCHARGE 47
665 VOCAL CORD PARALYSIS 47
666 BLOOD PRESSURE FLUCTUATION 46
667 CARDIAC FAILURE 46
668 DEAFNESS UNILATERAL 46
669 DRUG ABUSE 46
670 GENERALISED TONIC-CLONIC SEIZURE 46
671 PERSONALITY DISORDER 46
672 SCAB 46
673 THYROID DISORDER 46
674 TONGUE DISORDER 46
675 ABNORMAL BEHAVIOUR 45
676 BACTERIAL INFECTION 45
677 BLADDER SPASM 45
678 BLOOD CREATINE PHOSPHOKINASE INCREASED 45
679 DRUG DEPENDENCE 45
680 EYE INJURY 45
681 EYELID FUNCTION DISORDER 45
682 FLATULENCE 45
683 FOOT FRACTURE 45
684 HAEMORRHOIDS 45
685 LIBIDO INCREASED 45
686 PRODUCT USED FOR UNKNOWN INDICATION 45
687 RESPIRATORY TRACT CONGESTION 45
688 SINUS HEADACHE 45
689 SOFT TISSUE INJURY 45
690 WEIGHT FLUCTUATION 45
691 ANAL INCONTINENCE 44
692 BRUXISM 44
693 ELECTROCARDIOGRAM QT PROLONGED 44
694 GASTRITIS 44
695 HOSTILITY 44
696 INTENTIONAL DOSE OMISSION 44
697 PARANASAL CYST 44
698 SENSATION OF HEAVINESS 44
699 STERNAL FRACTURE 44
700 ANGER 43
701 CARDIO-RESPIRATORY ARREST 43
702 EYELID PAIN 43
703 IMMUNE SYSTEM DISORDER 43
704 MUSCLE FATIGUE 43
705 NASAL DISCOMFORT 43
706 PELVIC PAIN 43
707 RESTLESSNESS 43
708 VASCULAR MALFORMATION 43
709 CARPAL TUNNEL SYNDROME 42
710 DEMENTIA 42
711 DISEASE PROGRESSION 42
712 LID SULCUS DEEPENED 42
713 PNEUMOTHORAX 42
714 RAYNAUD^S PHENOMENON 42
715 TEMPOROMANDIBULAR JOINT SYNDROME 42
716 ALANINE AMINOTRANSFERASE INCREASED 41
717 BLADDER PAIN 41
718 CEREBRAL INFARCTION 41
719 FOOD ALLERGY 41
720 GLAUCOMA 41
721 PERONEAL NERVE PALSY 41
722 PREMATURE BABY 41
723 BREAST CANCER FEMALE 40
724 HYSTERECTOMY 40
725 JOINT INJURY 40
726 NEUROLOGICAL SYMPTOM 40
727 SPINAL FUSION SURGERY 40
728 UNRESPONSIVE TO STIMULI 40
729 ACCIDENTAL OVERDOSE 39
730 ATAXIA 39
731 DENTAL CARIES 39
732 HYPERTONIA 39
733 HYPOGLYCAEMIA 39
734 HYPONATRAEMIA 39
735 INCORRECT DOSE ADMINISTERED BY DEVICE 39
736 INFUSION SITE PAIN 39
737 INTERVERTEBRAL DISC DEGENERATION 39
738 LEUKOPENIA 39
739 LYMPHOCYTE COUNT DECREASED 39
740 MOUTH SWELLING 39
741 TEMPERATURE INTOLERANCE 39
742 BRAIN NEOPLASM 38
743 INITIAL INSOMNIA 38
744 OCCIPITAL NEURALGIA 38
745 PHARYNGEAL HYPOAESTHESIA 38
746 SPINAL OSTEOARTHRITIS 38
747 UPPER-AIRWAY COUGH SYNDROME 38
748 DERMATITIS ATOPIC 37
749 DRUG WITHDRAWAL SYNDROME 37
750 HEMIPLEGIA 37
751 POISONING 37
752 PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER 37
753 SKIN LACERATION 37
754 SKIN REACTION 37
755 BIPOLAR DISORDER 36
756 BLEPHARITIS 36
757 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 36
758 DERMATITIS ALLERGIC 36
759 DYSGRAPHIA 36
760 FEELING DRUNK 36
761 FORMICATION 36
762 GENERAL SYMPTOM 36
763 HERNIA 36
764 HORDEOLUM 36
765 MATERNAL EXPOSURE DURING BREAST FEEDING 36
766 NERVE COMPRESSION 36
767 DARK CIRCLES UNDER EYES 35
768 MOUTH ULCERATION 35
769 NYSTAGMUS 35
770 SKIN INFECTION 35
771 SKIN SWELLING 35
772 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 35
773 ABNORMAL DREAMS 34
774 APPLICATION SITE ERYTHEMA 34
775 BLOOD GLUCOSE DECREASED 34
776 CANDIDA INFECTION 34
777 CYANOSIS 34
778 EYE INFLAMMATION 34
779 EYELIDS PRURITUS 34
780 FEMUR FRACTURE 34
781 FOOD INTOLERANCE 34
782 INJECTION SITE SCAR 34
783 LOCALISED INFECTION 34
784 MATERNAL EXPOSURE BEFORE PREGNANCY 34
785 MOOD SWINGS 34
786 MUSCULOSKELETAL CHEST PAIN 34
787 NEPHROPATHY TOXIC 34
788 ORAL DISORDER 34
789 PLEURAL EFFUSION 34
790 POST-TRAUMATIC STRESS DISORDER 34
791 TOOTH FRACTURE 34
792 WRONG PRODUCT ADMINISTERED 34
793 ARTHROPOD BITE 33
794 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 33
795 DRUG ERUPTION 33
796 INJECTION SITE GRANULOMA 33
797 INJURY ASSOCIATED WITH DEVICE 33
798 MULTIPLE ALLERGIES 33
799 NEEDLE ISSUE 33
800 PHARYNGITIS STREPTOCOCCAL 33
801 PLATELET COUNT DECREASED 33
802 PUSTULAR PSORIASIS 33
803 QUALITY OF LIFE DECREASED 33
804 RHABDOMYOLYSIS 33
805 ALTERED STATE OF CONSCIOUSNESS 32
806 BLOOD URINE PRESENT 32
807 CENTRAL NERVOUS SYSTEM LESION 32
808 CEREBRAL DISORDER 32
809 DRUG ADMINISTRATION ERROR 32
810 FEELING JITTERY 32
811 HYPOAESTHESIA EYE 32
812 PARTIAL SEIZURES 32
813 BLOOD PRESSURE ABNORMAL 31
814 CHOLECYSTECTOMY 31
815 COORDINATION ABNORMAL 31
816 DIZZINESS POSTURAL 31
817 EYE HAEMORRHAGE 31
818 GINGIVAL PAIN 31
819 HERPES VIRUS INFECTION 31
820 HYPOXIA 31
821 MENSTRUAL DISORDER 31
822 RENAL PAIN 31
823 SKIN WARM 31
824 TARDIVE DYSKINESIA 31
825 UPPER LIMB FRACTURE 31
826 VITAMIN D DECREASED 31
827 AUTONOMIC NERVOUS SYSTEM IMBALANCE 30
828 BLOOD CREATININE INCREASED 30
829 CARDIAC FAILURE CONGESTIVE 30
830 COUNTERFEIT PRODUCT ADMINISTERED 30
831 DEVICE DISLOCATION 30
832 ECONOMIC PROBLEM 30
833 EXTRAOCULAR MUSCLE PARESIS 30
834 EYE OEDEMA 30
835 HAEMATOCHEZIA 30
836 KNEE OPERATION 30
837 LIP PAIN 30
838 MUSCLE HYPERTROPHY 30
839 MYOCLONUS 30
840 ODYNOPHAGIA 30
841 PHARYNGITIS 30
842 POSTNATAL GROWTH RESTRICTION 30
843 RASH PUSTULAR 30
844 RETINAL DETACHMENT 30
845 SINUS PAIN 30
846 SPONDYLITIS 30
847 TENDONITIS 30
848 UROSEPSIS 30
849 ADRENAL INSUFFICIENCY 29
850 DEVICE BREAKAGE 29
851 FINE MOTOR SKILL DYSFUNCTION 29
852 GASTRIC ULCER 29
853 HEPATIC FUNCTION ABNORMAL 29
854 INJECTION SITE INJURY 29
855 LACERATION 29
856 LIGAMENT SPRAIN 29
857 NEUROGENIC BLADDER 29
858 ON AND OFF PHENOMENON 29
859 POST PROCEDURAL INFECTION 29
860 ROTATOR CUFF SYNDROME 29
861 SPINAL FRACTURE 29
862 TOOTH INFECTION 29
863 VAGINAL HAEMORRHAGE 29
864 VITAMIN D DEFICIENCY 29
865 ACUTE RESPIRATORY FAILURE 28
866 ASPHYXIA 28
867 DECUBITUS ULCER 28
868 DERMATOCHALASIS 28
869 DRUG TOLERANCE DECREASED 28
870 EYELID IRRITATION 28
871 FACE INJURY 28
872 GASTROINTESTINAL MOTILITY DISORDER 28
873 GESTATIONAL HYPERTENSION 28
874 HIATUS HERNIA 28
875 INJECTION SITE EXTRAVASATION 28
876 INTRACRANIAL PRESSURE INCREASED 28
877 OBSTRUCTIVE AIRWAYS DISORDER 28
878 PARESIS 28
879 PRODUCT AVAILABILITY ISSUE 28
880 PRODUCT PRESCRIBING ISSUE 28
881 PRODUCT SUBSTITUTION ISSUE 28
882 SKIN CANCER 28
883 SUSPECTED OFF LABEL USE 28
884 SWOLLEN JOINT COUNT 28
885 TENSION 28
886 ABDOMINAL PAIN LOWER 27
887 ACCIDENT 27
888 AGGRESSION 27
889 APNOEA 27
890 DYSPHEMIA 27
891 FEELING OF BODY TEMPERATURE CHANGE 27
892 HEAD TITUBATION 27
893 NECK SURGERY 27
894 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 27
895 PRODUCT ADMINISTERED BY WRONG PERSON 27
896 RENAL IMPAIRMENT 27
897 SKIN LAXITY 27
898 SPINAL STENOSIS 27
899 STATUS EPILEPTICUS 27
900 TONGUE PARALYSIS 27
901 ULCER 27
902 ARTERIOSCLEROSIS CORONARY ARTERY 26
903 ATROPHY 26
904 AURA 26
905 AUTOIMMUNE THYROIDITIS 26
906 COLITIS 26
907 CYSTITIS NONINFECTIVE 26
908 FRACTURE 26
909 FRUSTRATION TOLERANCE DECREASED 26
910 GRANULOMA 26
911 HYDROCEPHALUS 26
912 HYPERVENTILATION 26
913 INJECTION SITE ATROPHY 26
914 MACULAR DEGENERATION 26
915 MENTAL STATUS CHANGES 26
916 NASAL DRYNESS 26
917 PROCEDURAL COMPLICATION 26
918 PRODUCT CONTAMINATION 26
919 PRODUCT LABEL ISSUE 26
920 PRODUCT USE COMPLAINT 26
921 RHINALGIA 26
922 SKIN ATROPHY 26
923 SKIN ODOUR ABNORMAL 26
924 STRIDOR 26
925 TOOTH LOSS 26
926 URINARY BLADDER HAEMORRHAGE 26
927 APPLICATION SITE PRURITUS 25
928 AREFLEXIA 25
929 CLOSTRIDIUM DIFFICILE INFECTION 25
930 EXPOSURE VIA BREAST MILK 25
931 EXPOSURE VIA SKIN CONTACT 25
932 EYE OPERATION 25
933 INCREASED TENDENCY TO BRUISE 25
934 INJECTION RELATED REACTION 25
935 MALNUTRITION 25
936 MANUFACTURING PRODUCT SHIPPING ISSUE 25
937 ORTHOSTATIC HYPOTENSION 25
938 PHARYNGEAL DISORDER 25
939 PSYCHOTIC DISORDER 25
940 PULMONARY OEDEMA 25
941 SCOLIOSIS 25
942 SKIN ULCER 25
943 SUDDEN DEATH 25
944 SUPRAVENTRICULAR TACHYCARDIA 25
945 VOCAL CORD DISORDER 25
946 ANKLE FRACTURE 24
947 ASPARTATE AMINOTRANSFERASE INCREASED 24
948 CERVICOGENIC HEADACHE 24
949 EXTRA DOSE ADMINISTERED 24
950 GASTROENTERITIS 24
951 GASTROINTESTINAL PAIN 24
952 HAIR TEXTURE ABNORMAL 24
953 IMMUNOSUPPRESSION 24
954 INCREASED UPPER AIRWAY SECRETION 24
955 INDURATION 24
956 IRON DEFICIENCY ANAEMIA 24
957 LEFT VENTRICULAR FAILURE 24
958 LIQUID PRODUCT PHYSICAL ISSUE 24
959 MAST CELL ACTIVATION SYNDROME 24
960 MULTIPLE ORGAN DYSFUNCTION SYNDROME 24
961 NASAL OEDEMA 24
962 NEOPLASM 24
963 NO THERAPEUTIC RESPONSE 24
964 NONSPECIFIC REACTION 24
965 OESOPHAGEAL DISORDER 24
966 PRODUCT DOSE OMISSION IN ERROR 24
967 PRODUCT PRESCRIBING ERROR 24
968 RED BLOOD CELL COUNT DECREASED 24
969 RESIDUAL URINE VOLUME INCREASED 24
970 SUICIDE ATTEMPT 24
971 THROMBOCYTOPENIA 24
972 VASCULAR OCCLUSION 24
973 VENTRICULAR EXTRASYSTOLES 24
974 APPENDICITIS 23
975 CARDIOVASCULAR DISORDER 23
976 CHEILITIS 23
977 DRUG TOXICITY 23
978 FAECAL INCONTINENCE 23
979 HALLUCINATION, VISUAL 23
980 HORMONE LEVEL ABNORMAL 23
981 LIMB OPERATION 23
982 MENOPAUSE 23
983 MIGRAINE WITHOUT AURA 23
984 NOCTURIA 23
985 ORAL CANDIDIASIS 23
986 PHYSICAL DECONDITIONING 23
987 ROSACEA 23
988 SENSATION OF PRESSURE 23
989 SENSITIVE SKIN 23
990 SHOULDER OPERATION 23
991 SKIN HAEMORRHAGE 23
992 SLOW SPEECH 23
993 SYMPTOM RECURRENCE 23
994 THERAPY CHANGE 23
995 VEIN DISORDER 23
996 ACCOMMODATION DISORDER 22
997 AMYOTROPHIC LATERAL SCLEROSIS 22
998 CIRCULATORY COLLAPSE 22
999 CUTIS LAXA 22